Current practices in patient-reported outcome (PRO) data collection in clinical trials: a cross-sectional survey of UK trial staff and management

BMJ Open

Volumn 6, Issue 10, 2016, Pages

  Kyte, Derek ^a   Ives, Jonathan ^b   Draper, Heather ^a   Calvert, Melanie ^a  

^a UNIVERSITY OF BIRMINGHAM   (United Kingdom)

^b UNIVERSITY OF BRISTOL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; CLINICAL RESEARCH; CONSENSUS; CONSULTATION; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MANAGER; NURSE; OUTCOME ASSESSMENT; PATIENT CARE; PATIENT-REPORTED OUTCOME; QUALITATIVE RESEARCH; QUANTITATIVE ANALYSIS; THEMATIC ANALYSIS; CROSS-SECTIONAL STUDY; MEASUREMENT ACCURACY; MEDICAL RESEARCH; METHODOLOGY; MIDDLE AGED; PERSONNEL; QUESTIONNAIRE; STANDARDS; STATISTICAL BIAS; UNITED KINGDOM; YOUNG ADULT;

ADULT; BIAS; BIOMEDICAL RESEARCH; CROSS-SECTIONAL STUDIES; DATA ACCURACY; HUMANS; MIDDLE AGED; PATIENT REPORTED OUTCOME MEASURES; QUALITATIVE RESEARCH; RESEARCH DESIGN; RESEARCH PERSONNEL; SURVEYS AND QUESTIONNAIRES; UNITED KINGDOM; YOUNG ADULT;

EID: 85030784790     PISSN: None     EISSN: 20446055     Source Type: Journal    
DOI: 10.1136/BMJOPEN-2016-012281     Document Type: Article

References (25)

1. Basch EM, Abernethy A, Mullins CD, et al. Development of a guidance for including patient-reported outcomes (PROS) in post-approval clinical trials of oncology drugs for comparative effectiveness research (CER). Value Health 2011;14:A10.
2. Calvert MJ, Freemantle N. Use of health-related quality of life in prescribing research. Part 1: why evaluate health-related quality of life? J Clin Pharm Ther 2003;28:513-21.
3. Devlin NJ, Appleby J. Getting the most out of PROMS-putting health outcomes at the heart of NHS decision-making. The King's Fund, 2010.
4. FDA. Guidance for Industry: Patient-Reported Outcome Measures: Use in Medical Product Development to Support Labeling Claims. 2009. http://wwwfdagov/downloads/Drugs/GuidanceCompliance RegulatoryInformation/Guidances/UCM193282pdf
5. Fielding S, Maclennan G, Cook JA, et al. A review of RCTs in four medical journals to assess the use of imputation to overcome missing data in quality of life outcomes. Trials 2008;9:51.
6. Fairclough DL, Peterson HF, Chang V. Why are missing quality of life data a problem in clinical trials of cancer therapy? Stat Med 1998;17:667-77.
7. Bernhard J, Cella DF, Coates AS, et al. Missing quality of life data in cancer clinical trials: serious problems and challenges. Stat Med 1998;17:517-32.
8. Bernhard J, Peterson HF, Coates AS, et al. Quality of life assessment in International Breast Cancer Study Group (IBCSG) trials: practical issues and factors associated with missing data. Stat Med 1998;17:587-601.
9. Bhardwaj A, Rehman SU, Mohammed AA, et al. Quality of life and chronic heart failure therapy guided by natriuretic peptides: results from the ProBNP Outpatient Tailored Chronic Heart Failure Therapy (PROTECT) study. Am Heart J 2012;164:793-9.
10. Simes RJ, Greatorex V, Gebski VJ. Practical approaches to minimize problems with missing quality of life data. Stat Med 1998;17:725-37.
11. Chan A, Tetzlaff JM, Gøtzsche PC, et al. SPIRIT 2013 explanation and elaboration: guidance for protocols of clinical trials. BMJ 2013;346:1-42.
12. Sajdak R, Trembath L, Thomas KS. The importance of standard operating procedures in clinical trials. J Nucl Med Technol 2013;41:231-3.
13. Kyte D, Ives J, Draper H, et al. Inconsistencies in quality of life data collection in clinical trials: a potential source of bias? Interviews with research nurses and trialists. PLoS ONE 2013;8:e76625.
14. Kyte D, Draper H, Calvert M. Patient-reported outcome alerts: ethical and logistical considerations in clinical trials. JAMA 2013;310: 1229-30.
15. Kyte D, Ives J, Draper H, et al. Management of patient-reported outcome (PRO) alerts in clinical trials: a cross sectional survey. PLoS ONE 2016;11:e0144658.
16. Kyte DG, Draper H, Ives J, et al. Patient reported outcomes (PROs) in clinical trials: is 'in-trial' guidance lacking? a systematic review. PLoS ONE 2013;8:e60684.
17. Peduzzi P, Concato J, Kemper E, et al. A simulation study of the number of events per variable in logistic regression analysis. J Clin Epidemiol 1996;49:1373-9.
18. Hsieh HF, Shannon SE. Three approaches to qualitative content analysis. Qual Health Res 2005;15:1277-88.
19. Calvert M, Kyte D, von Hildebrand M, et al. Putting patients at the heart of health-care research. Lancet 2015;385: 1073-4.
20. Leidy NK, Revicki DA, Genesté B. Recommendations for evaluating the validity of quality of life claims for labeling and promotion. Value Health 1999;2:113-27.
21. Luo X, Cappelleri JC. A practical guide on incorporating and evaluating patient-reported outcomes in clinical trials. Clin Res Regul Aff 2008;25:197-211.
22. Macmillan NA, Creelman CD. Response bias: Characteristics of detection theory, threshold theory, and 'nonparametric' indexes. Psychol Bull 1990;107:401.
23. Friedman LM, Furberg C, DeMets DL. Fundamentals of clinical trials. Springer, 2010.
24. Chalmers I, Glasziou P. Avoidable waste in the production and reporting of research evidence. Lancet 2009;374:86-9.
25. Kyte D, Duffy H, Fletcher B, et al. Systematic evaluation of the patient-reported outcome (PRO) content of clinical trial protocols. PLoS ONE 2014;9:e110229.